OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selected Approaches to Disrupting Protein–Protein Interactions within the MAPK/RAS Pathway
Stephen J. Harwood, Christopher R. Smith, J. David Lawson, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7373-7373
Open Access | Times Cited: 9
Stephen J. Harwood, Christopher R. Smith, J. David Lawson, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7373-7373
Open Access | Times Cited: 9
Showing 9 citing articles:
RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives
Dana Alawieh, Leila Cysique-Foinlan, Christophe Willekens, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Dana Alawieh, Leila Cysique-Foinlan, Christophe Willekens, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading
Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 10, pp. 1418-1430
Open Access | Times Cited: 11
Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 10, pp. 1418-1430
Open Access | Times Cited: 11
Research progress on small molecule inhibitors targeting KRAS G12C with acrylamide structure and the strategies for solving KRAS inhibitor resistance
Zhiyan Jiang, Yan Li, Xin Zhou, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 100, pp. 117627-117627
Closed Access | Times Cited: 4
Zhiyan Jiang, Yan Li, Xin Zhou, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 100, pp. 117627-117627
Closed Access | Times Cited: 4
Evaluation of the Inhibitory Potential of Apigenin and Related Flavonoids on Various Proteins Associated with Human Diseases Using AutoDock
Tanat Peanlikhit, Uma K. Aryal, James S. Welsh, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2548-2548
Open Access
Tanat Peanlikhit, Uma K. Aryal, James S. Welsh, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2548-2548
Open Access
In silico comparison of apigenin and related compounds with diverse pharmacological activities using AutoDock 4.2.6
Tanat Peanlikhit, Uma K. Aryal, James S. Welsh, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Tanat Peanlikhit, Uma K. Aryal, James S. Welsh, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
The role of GRB2 in diabetes, diabetes complications and related disorders
Jing Ma, Yuyan Dong, Juxiang Liu, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Jing Ma, Yuyan Dong, Juxiang Liu, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 1
Investigation into the potential mechanism and therapeutic targets of Cangzhu Erchen decoction for the treatment of chronic obstructive pulmonary disease based on bioinformatics and network pharmacology
Xiaofei Gu, Jiangang Ju, Qingqing Chen, et al.
Medicine (2024) Vol. 103, Iss. 33, pp. e39338-e39338
Open Access
Xiaofei Gu, Jiangang Ju, Qingqing Chen, et al.
Medicine (2024) Vol. 103, Iss. 33, pp. e39338-e39338
Open Access
Insights into direct KRAS inhibition strategies for cancer treatment
Tong Li, Chenglei Gu, Chen Zhou, et al.
Future Medicinal Chemistry (2024), pp. 1-19
Closed Access
Tong Li, Chenglei Gu, Chen Zhou, et al.
Future Medicinal Chemistry (2024), pp. 1-19
Closed Access
The permissive binding theory of cancer
Caroline M. Weisman
Frontiers in Oncology (2023) Vol. 13
Open Access
Caroline M. Weisman
Frontiers in Oncology (2023) Vol. 13
Open Access
